相关实验视频
Updated: Jul 5, 2025

Optimized Analysis of In Vivo and In Vitro Hepatic Steatosis
Published on: March 11, 2017
关于发展非酒精性脂肪性肝病中的刺痛信号通路的最新情况
Wei Liu1, Zhili Zhang Chen1, Chenhui Yang1
1Department of Endocrinology and Metabolism, Affiliated Hospital of Integrated Traditional Chinese and Western Medicine, Nanjing University of Chinese Medicine, Nanjing, Jiangsu, China.
非酒精性脂肪性肝病 (NAFLD) 涉及由STING通路调节的炎症. 向STING为NAFLD治疗提供了有前途的新治疗策略.
科学领域:
- 肝病学 肝病学是一种肝病学.
- 免疫学 免疫学 免疫学
- 分子生物学分子生物学
背景情况:
- 非酒精性脂肪性肝病 (NAFLD) 是一种广泛的慢性肝病,有效治疗方法很少.
- 由代谢问题驱动的炎症是NAFLD进展的关键因素.
- 干扰素基因刺激器 (STING) 途径对先天免疫至关重要,它对细胞质DNA作出反应,引发炎症反应.
研究的目的:
- 探索STING信号通路在与NAFLD相关的肝炎和代谢功能障碍中的作用.
- 调查针对NAFLD治疗的STING途径的治疗潜力.
主要方法:
- 关于肝脏疾病中STING信号的当前文献的综述.
- 对STING参与与NAFLD相关的免疫细胞通路 (巨细胞,树突细胞,NK细胞,T细胞) 的分析.
- 在NAFLD模型中对STING抑制剂的临床前和临床数据的评估.
主要成果:
- 针路径与NAFLD的发病过程有关,有助于肝炎和代谢障碍.
- 药理上抑制STING已经证明对NAFLD病理有积极影响.
- 由STING调节的免疫细胞通路代表了潜在的新型治疗点.
结论:
- STING途径是NAFLD发展和进展的重要贡献者.
- 准STING为NAFLD提供了一个有前途的治疗途径.
- 对STING调节的免疫机制的进一步研究可能会为NAFLD带来新的治疗策略.
更多相关视频
07:03Author Spotlight: Establishing MASLD Cell Models for Investigating Disease Mechanisms and the Lipid-Lowering Effects of Koumiss
Published on: July 19, 2024
08:41Novel In Vivo Micro-Computed Tomography Imaging Techniques for Assessing the Progression of Non-Alcoholic Fatty Liver Disease
Published on: March 24, 2023
相关概念视频
Inflammation
Liver Regeneration
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are...
Notch Signaling Pathway
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not...